iNtRON Biotechnology Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - iNtRON Biotechnology Inc

Watchlist Manager

Watchlist

Price: 2 725 KRW 0.93% Market Closed

Market Cap: ₩84.2B

I	iNtRON Biotechnology Inc KOSDAQ:048530	KR
	Olin Corp NYSE:OLN	US
	Orexo AB F:C5G	SE
	WT Microelectronics Co Ltd TWSE:3036	TW
	Santec Holdings Corp F:8AU	JP
	Cooper-Standard Holdings Inc NYSE:CPS	US
O	Osang HealthCare Co Ltd KOSDAQ:036220	KR
S	Seowonintech Co Ltd KOSDAQ:093920	KR

Profitability Summary

iNtRON Biotechnology Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

50%

Strong 3Y Average Gross Margin

57%

Declining Gross Margin

56% > 50%

Negative Operating Margin

-109%

Negative 3Y Average Operating Margin

-92%

Declining Operating Margin

-51% > -109%

Negative Net Margin

-143%

Negative 3Y Average Net Margin

-100%

Declining Net Margin

-115% > -143%

Negative Free Cash Flow Margin

-94%

Negative 3Y Average Free Cash Flow Margin

-89%

Declining Free Cash Flow Margin

1% > -94%

Negative ROE

-15%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-17%

Declining ROIC

-10% > -24%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.